CHI Launches PEGS Asia Event in Shanghai

Protein & Antibody Engineering and Development Summit, April 1-3, 2014
Spread the Word
Listed Under

* Biotech
* Pharma
* Biopharm
* Life Sciences
* Protein-engineering

* Science

* US

* Events

Feb. 19, 2014 - PRLog -- Cambridge Healthtech Institute (CHI) is excited about the launch of its first PEGS Asia event in Shanghai, China, to be held from April 1-3, 2014. "PEGS China: Protein & Antibody Engineering and Development Summit" is spurred by the growth in the biopharmaceutical sector in Asia and the demand by conference participants and exhibitors to bring higher quality, established and credible conferences to this region.

A 3-day event comprised of 4 conferences featuring over 55 presentations of practical case studies and proven strategies, 15 roundtable discussions with interactive participation in problem solving and future collaborations, a plenary keynote session featuring leading international and China Biotechnologists, and over 50 hours of knowledge and contact exchanges.

The conferences represent the four pillars of biopharmaceutical development, namely:

Protein & Antibody Engineering
Analytical Characterization and Stability
Optimizing Protein Expression
Quality, Scalability and CMC Strategies

The topic-focused conferences offer a unique opportunity to learn the latest tools and techniques that will help you engineer your protein/antibody for better efficacy and safety; optimize your proteins for higher productivity; better characterize your products for stability and comparability; as well as develop processes to ensure product quality, consistency and scalability.

PEGS is CHI's flagship biologics event, and considered the industry leading event. Attracting over 1,600 participants at the PEGS Summit in Boston, and a record attendance at the PEGS Europe event held recently in Lisbon, the first PEGS China is expected to attract over 250 attendees including scientists, engineers and executives involved in protein/antibody engineering, expression, cell line development, next generation biologics including ADCs and bispecifics, biosimilars, analytical development, formulation, processing and manufacturing.

Registration options allow you to attend just 1 or all 4 conferences. For details, visit

Exhibit and sponsorship opportunities are available. For details, contact Carol Dinerstein, 781-972-5471,

Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi,

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group. For more information, visit

Cambridge Healthtech Institute
Email:*** Email Verified
Tags:Biotech, Pharma, Biopharm, Life Sciences, Protein-engineering
Location:United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Daily News
Weekly News

Like PRLog?
Click to Share